Follicular lymphoma grade II, extranodal and solid organ sites
ICD-10 C82.19 is a billable code used to indicate a diagnosis of follicular lymphoma grade ii, extranodal and solid organ sites.
Follicular lymphoma grade II is a type of non-Hodgkin lymphoma characterized by the proliferation of follicle center (germinal center) B-cells. This subtype is classified as grade II due to its intermediate histological features, which indicate a higher proliferation rate than grade I but lower than grade III. Extranodal involvement refers to the presence of lymphoma outside of lymph nodes, affecting solid organ sites such as the spleen, liver, or bone marrow. Patients may present with B-symptoms, which include fever, night sweats, and unexplained weight loss. Diagnosis typically involves imaging studies, biopsy, and immunophenotyping to confirm the presence of CD10, CD19, and BCL2 markers. Treatment protocols often include chemotherapy regimens such as R-CHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone) or targeted therapies, depending on the stage and patient factors. The prognosis varies based on the extent of disease and response to initial therapy.
Comprehensive clinical notes, pathology reports, imaging studies, and treatment plans.
Diagnosis and management of patients with newly diagnosed follicular lymphoma, monitoring treatment response, and managing relapsed disease.
Ensure accurate documentation of staging and treatment response to support coding and billing.
Detailed histopathology reports, immunohistochemistry results, and grading information.
Biopsy interpretation for suspected lymphoma cases and grading of lymphoma specimens.
Accurate reporting of immunophenotyping results is crucial for correct coding.
Used for administering chemotherapy to patients with follicular lymphoma.
Document the specific chemotherapy regimen and patient response.
Oncology specialists must ensure accurate coding of chemotherapy administration.
Common symptoms include painless swelling of lymph nodes, fever, night sweats, weight loss, and fatigue. Some patients may also experience abdominal discomfort if there is splenic or liver involvement.
